Gliclazide is an active pharmaceutical ingredient (API) belonging to the second-generation sulfonylurea class of drugs.
This raw material is commonly used to manufacture drugs for the treatment of type 2 diabetes.
The mechanism of action of Gliclazide is to stimulate the beta cells of the pancreas to secrete insulin, thereby helping to control and lower blood sugar levels effectively.
This raw material acts as a core ingredient, widely used to produce type 2 diabetes (non-insulin-dependent diabetes) medications for adult patients when diet and exercise are insufficient to control the disease.
2. Gliclazide Raw Material Information
Raw material name: Gliclazide
Material group: Active Pharmaceutical Ingredient (API) / Antidiabetic drug.
Appearance: White or almost white crystalline powder.
Solubility: Practically insoluble in water, freely soluble in dichloromethane, sparingly soluble in acetone and ethanol.
Control characteristics: The content of active ingredients and impurities is strictly controlled to ensure safety and bioavailability when formulating drugs.
Biorich Group supplies Camphor - an active pharmaceutical ingredient (API) that helps relieve pain, prevent itching, and create a cooling sensation. Optimally applied in ointments, medicated oils, massage balms, and cosmetics. Contact us now to receive a sample and COA!
Ketoprofen Raw Material – International standard Active Pharmaceutical Ingredient (API), widely used in the formulation of analgesic and anti-inflammatory drugs. Contact Biorich now!
Chlorhexidine Gluconate – Highly effective antibacterial and surface antiseptic solution. Widely applied in healthcare and personal care. Contact Biorich now!
Calcium Silicate - Outstanding anti-caking, flow-enhancing, and absorbing agent for pharmaceutical and food production. Contact Biorich now!
Biorich Group
Thông tin
Biorich Group provides raw materials and supply chain solutions for the pharmaceutical, nutrition, healthcare, cosmetics, food, and industrial sectors, with a global network of partners.
Main category
Loading...
Featured videos
Sign up to receive news
Sign up for our weekly newsletter to get the latest updates.